Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel + 5-fluorouracil vs cisplatin + 5-fluorouracil with concurrent radiotherapy in locally advanced esophageal squamous cell carcinoma
ChiCTR2500100712Phase 3Completed
- Sponsor
- Affiliated Hospital of Jiangnan University
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, cisplatin, fluorouracil in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Affiliated Hospital of Jiangnan University. Started Apr 2025; status: completed.
02
Drugs
paclitaxelcisplatinfluorouracil
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on ChiCTR2500100712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100712.